查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611110

神经调节设备的全球市场规模、份额和趋势分析：按产品、应用、最终用途和地区（2025-2030）

Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson's Disease, Chronic Pain), By End-use, By Region, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

神经调节设备市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球神经调节设备市场规模将达到103.9亿美元，2025年至2030年复合年增长率为8.51%。

市场成长的原因包括神经系统疾病盛行率上升、政府对研发的支持力度加大以及先进解决方案的开发和应用范围的扩大等。

政府和私人机构的大量资助在增进对神经系统疾病的了解和改善治疗方法发挥着重要作用。透过向研究倡议分配资源，政府积极培养突破性发现，鼓励创新，并促进更有效的神经调节技术的发展。例如，帕金森基金会于 2024 年 8 月宣布，将向 33 项研究津贴约 300 万美元，旨在促进对帕金森氏症 (PD) 的了解和治疗。这笔津贴将支持专注于帕金森氏症各个方面的创新研究计划，包括其病因、进展和潜在的治疗方法。这笔津贴是基金会致力于促进科学进步、改善病患治疗效果的承诺的一部分。这种财政支持对于塑造神经系统疾病的治疗格局和为患者护理带来积极的变化至关重要。

此外，这些先进设备对患者和医疗保健专业人员的可用性不断提高，进一步提高了它们的采用率。医疗费用的增加也增加了患者获得这些先进治疗的机会。近年来，医疗保健系统越来越认识到神经调节设备在治疗慢性疼痛、神经系统疾病和各种其他医疗状况方面的有效性，许多医疗保健支付者将这些设备纳入其承保政策中。例如，2024年2月，在美国，Highmark Inc.因其Nerivio远端电神经调节（REN）穿戴装置成为首个获得商业保险承保的非药物偏头痛治疗药物。这款穿戴式装置提供急性和预防性治疗选择，并在缓解偏头痛症状方面显示出显着的临床疗效。付款人对神经调节疗法的日益接受度正在推动市场成长。

神经调节设备市场报告亮点

  • 脊髓刺激装置占最大市场占有率，2024年约为39.67%。脊髓刺激装置主要用于非手术疼痛治疗无法充分缓解疼痛的患者。
  • 帕金森氏症占最大市场占有率，2024年约为26.90%。帕金森氏症患者病率不断上升，加上人们越来越接受深部脑部刺激作为有效的治疗选择，预计将推动该领域的成长。
  • 到 2024 年，医院和门诊手术中心 (ASC) 占据最大的市场占有率，预计该细分市场在预测期内将呈现最快的成长。
  • 由于阿兹海默症、帕金森氏症、癫痫等各种神经疾病的盛行率不断增加，以及对微创神经手术的需求不断增加，2024年北美神经调节设备市场将占据43.68%的份额。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 神经调节装置的变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 神经调节装置分析工具
    • 产业分析：波特五力分析
    • PESTEL分析

第 4 章 神经调节设备市场 - 細項分析：依产品（2018-2030）

  • 神经调节设备市场：产品展望与要点
  • 神经调节设备市场：产品变异分析
  • 副产品
  • 脊髓刺激装置
    • 脊髓刺激装置市场（2018-2030）
  • 脑深部电刺激装置
    • 脑深部刺激设备市场（2018-2030）
  • 荐椎神经刺激装置
    • 荐椎神经刺激装置市场（2018-2030）
  • 迷走神经刺激装置
    • 迷走神经刺激装置市场（2018-2030）
  • 胃电刺激
    • 胃电刺激市场（2018-2030）
  • 其他的
    • 其他市场（2018-2030）

第 5 章 神经调节设备市场 - 細項分析：依应用分类（2018-2030）

  • 神经调节设备市场：应用前景与重点
  • 神经调节设备市场：应用变化分析
  • 按用途
  • 帕金森氏症
    • 帕金森氏症市场（2018-2030）
  • 慢性疼痛
    • 慢性疼痛市场（2018-2030）
  • 癫痫
    • 癫痫市场（2018-2030）
  • 偏头痛
    • 偏头痛市场（2018-2030）
  • 尿失禁和大便失禁
    • 尿失禁和大便失禁市场（2018-2030）
  • 震颤
    • 震颤市场（2018-2030）
  • 忧郁症
    • 忧郁症市场（2018-2030）
  • 其他的
    • 其他市场（2018-2030）

第 6 章 神经调节设备市场 - 細項分析：依最终用途分类（2018-2030）

  • 神经调节设备市场：最终用途展望与要点
  • 神经调节设备市场：最终用途变化分析
  • 按最终用途
  • 医院和门诊手术中心 (ASC)
    • 医院和门诊手术中心 (ASC) 市场（2018-2030）
  • 诊所和物理治疗中心
    • 诊所和物理治疗中心市场（2018-2030）
  • 其他的
    • 其他市场（2018-2030）

第七章神经调节设备市场：区域估计与趋势分析

  • 区域仪表板
  • 市场规模及预测趋势分析（2018-2030）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 主要市场参与企业的最新趋势和影响分析
  • 企业市场占有率分析：2024 年
  • 主要企业简介
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Nexstim
    • LivaNova PLC
    • Neuropace Inc.
    • Nevro Corporation
    • electroCore, Inc.
    • Axonics, Inc.
    • Laborie
Product Code: GVR-4-68039-958-9

Neuromodulation Devices Market Growth & Trends:

The global neuromodulation devices market size is expected to reach USD 10.39 billion by 2030, registering a CAGR of 8.51% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market's growth can be attributed to factors such as rising prevalence of neurological disorders, rising government support to R&D and development of advanced solutions with increased range of applications.

Significant funding from government and private agencies plays a crucial role in advancing the understanding of neurological disorders and improving treatment options. By allocating resources to research initiatives, governments actively facilitate groundbreaking discoveries, encourage technological innovations, and promote the development of more effective neuromodulation technologies. For instance, in August 2024, the Parkinson's Foundation announced an investment of nearly USD 3 million in 33 research grants aimed at advancing the understanding and treatment of Parkinson's disease (PD). This funding will support innovative research projects focusing on various aspects of PD, including its causes, progression, and potential therapies. The grants are part of the Foundation's commitment to fostering scientific advancements that can lead to improved patient outcomes. This financial backing is vital for shaping the treatment landscape for neurological disorders and driving positive changes in patient care.

Furthermore, the increasing accessibility of these advanced devices to patients and healthcare professionals has further increased their adoption. Expanding reimbursement is improving patient access to these advanced therapies. In recent years, healthcare systems have increasingly acknowledged the effectiveness of neuromodulation devices in managing chronic pain, neurological disorders, and various other medical conditions, which has led many healthcare payers to include these devices in their coverage policies. For instance, in February 2024, Nerivio Remote Electrical Neuromodulation (REN) wearable by Theranica became the first non-pharmacological migraine treatment to get commercial coverage in the U.S. from Highmark Inc. The wearable offers acute and preventive treatment options, demonstrating significant clinical benefits in reducing migraine symptoms. Thus, the growing acceptance of neuromodulation therapies among payers is driving market growth.

Neuromodulation Devices Market Report Highlights:

  • Spinal cord stimulators held the largest market share of around 39.67% in 2024. Spinal cord stimulation devices are primarily used for patients without sufficient pain relief from non-surgical pain treatments.
  • Parkinson's disease held the largest market share of around 26.90% in 2024. The rising prevalence of Parkinson's disease, coupled with the increasing acceptance of deep brain stimulation as an effective treatment option, is expected to drive segment growth.
  • Hospitals & Ambulatory Surgery Centers (ASC) held the largest market share in 2024 and the same segments are expected to show fastest growth during the forecast period.
  • North America neuromodulation devices market dominated with a share of 43.68% in 2024, owing to increase in the prevalence of various neurological disorders, such as Alzheimer's disease, Parkinson's disease, and epilepsy, and a rise in the demand for minimally invasive neurological procedures.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Neuromodulation Devices Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Government funding for research and development
      • 3.2.1.2. Technological advancements in neuromodulation devices
      • 3.2.1.3. Increasing prevalence of neurological disorders
      • 3.2.1.4. Growing reimbursement coverage
      • 3.2.1.5. Expanding applications
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complex regulatory framework
      • 3.2.2.2. Surgery-associated risk
  • 3.3. Neuromodulation Devices Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neuromodulation Devices Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1. Neuromodulation Devices Market: Product Outlook and Key Takeaways
  • 4.2. Neuromodulation Devices Market: Product Movement Analysis
  • 4.3. Neuromodulation Devices Market Estimates & Forecast, by Product (USD Million)
  • 4.4. Spinal Cord Stimulators
    • 4.4.1. Spinal Cord Stimulators Market, 2018 - 2030 (USD Million)
  • 4.5. Deep Brain Stimulators
    • 4.5.1. Deep Brain Stimulators Market, 2018 - 2030 (USD Million)
  • 4.6. Sacral Nerve Stimulators
    • 4.6.1. Sacral Nerve Stimulators Market, 2018 - 2030 (USD Million)
  • 4.7. Vagus Nerve Stimulators
    • 4.7.1. Vagus Nerve Stimulators Market, 2018 - 2030 (USD Million)
  • 4.8. Gastric Electrical Stimulation
    • 4.8.1. Gastric Electrical Stimulation Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Neuromodulation Devices Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 5.1. Neuromodulation Devices Market: Application Outlook and Key Takeaways
  • 5.2. Neuromodulation Devices Market: Application Movement Analysis
  • 5.3. Neuromodulation Devices Market Estimates & Forecast, by Application (USD Million)
  • 5.4. Parkinson's Disease
    • 5.4.1. Parkinson's Disease Market, 2018 - 2030 (USD Million)
  • 5.5. Chronic Pain
    • 5.5.1. Chronic Pain Market, 2018 - 2030 (USD Million)
  • 5.6. Epilepsy
    • 5.6.1. Epilepsy Market, 2018 - 2030 (USD Million)
  • 5.7. Migraine
    • 5.7.1. Migraine Market, 2018 - 2030 (USD Million)
  • 5.8. Urinary & Faecal Incontinence
    • 5.8.1. Urinary & Faecal Incontinence Market, 2018 - 2030 (USD Million)
  • 5.9. Tremor
    • 5.9.1. Tremor Market, 2018 - 2030 (USD Million)
  • 5.10. Depression
    • 5.10.1. Depression Market, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Neuromodulation Devices Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)

  • 6.1. Neuromodulation Devices Market: End Use Outlook and Key Takeaways
  • 6.2. Neuromodulation Devices Market: End Use Movement Analysis
  • 6.3. Neuromodulation Devices Market Estimates & Forecast, by End Use (USD Million)
  • 6.4. Hospitals & Ambulatory Surgery Centers (ASC)
    • 6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) Market, 2018 - 2030 (USD Million)
  • 6.5. Clinics & Physiotherapy Centers
    • 6.5.1. Clinics & Physiotherapy Centers Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million

Chapter 7. Neuromodulation Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Recent Developments & Impact Analysis by Key Market Participants
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Key Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Medtronic
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Boston Scientific Corporation
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Nexstim
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. LivaNova PLC
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Neuropace Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Nevro Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. electroCore, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Axonics, Inc.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Laborie
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America neuromodulation devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 4 North America neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 7 U.S. neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 10 Canada neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Mexico neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 13 Mexico neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe neuromodulation devices market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 17 Europe neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 20 Germany neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 UK neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 23 UK neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 France neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 26 France neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 27 France neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Italy neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 29 Italy neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Spain neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Spain neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Denmark neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Denmark neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Sweden neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 38 Sweden neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Norway neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 41 Norway neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific neuromodulation devices market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 48 China neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 49 China neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Japan neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Japan neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 India neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 54 India neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 55 India neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 57 South Korea neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Australia neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Australia neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Thailand neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 63 Thailand neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 66 Latin America neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Brazil neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Brazil neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 70 Brazil neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Argentina neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Argentina neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 73 Argentina neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 MEA neuromodulation devices market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 76 MEA neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 77 MEA neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 South Africa neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 79 South Africa neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Africa neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 UAE neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 85 UAE neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 86 UAE neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 89 Kuwait neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neuromodulation devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot (global and regional)
  • Fig. 8 Product & end use segment snapshot
  • Fig. 9 Application segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Neurovascular devices market and neuromodulation devices market value
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 PESTLE analysis
  • Fig. 14 Neuromodulation devices market: Product outlook and key takeaways
  • Fig. 15 Neuromodulation devices market: Product movement analysis
  • Fig. 16 Spinal cord stimulation market estimates and forecast
  • Fig. 17 Deep brain stimulation market estimates and forecast
  • Fig. 18 Vagus nerve stimulation market estimates and forecast
  • Fig. 19 Sacral nerve stimulation market estimates and forecast
  • Fig. 20 Gastric electrical stimulation market estimates and forecast
  • Fig. 21 Others market estimates and forecast
  • Fig. 22 Neuromodulation devices market: Application outlook and key takeaways
  • Fig. 23 Neuromodulation devices market: Application movement analysis
  • Fig. 24 Parkinson's disease market estimates and forecast
  • Fig. 25 Chronic pain market estimates and forecast
  • Fig. 26 Migraine market estimates and forecast
  • Fig. 27 Epilepsy market estimates and forecast
  • Fig. 28 Tremor market estimates and forecast
  • Fig. 29 Country-wise depression prevalence
  • Fig. 30 Depression market estimates and forecast
  • Fig. 31 Urinary & fecal incontinence market estimates and forecast
  • Fig. 32 Others incontinence market estimates and forecast
  • Fig. 33 Neuromodulation devices market: End-use outlook and key takeaways
  • Fig. 34 Neuromodulation devices market: End-use movement analysis
  • Fig. 35 Hospitals & ambulatory surgical centers market estimates and forecast
  • Fig. 36 Clinics & physiotherapy centers market estimates and forecast
  • Fig. 37 Others market estimates and forecast
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Regional marketplace: Key takeaways
  • Fig. 40 North America neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 U.S. neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Mexico neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 UK neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Germany neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 France neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Italy neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Spain neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Sweden neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Denmark neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Norway neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Japan neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 China neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 India neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Australia neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 New Zealand neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 South Korea neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Thailand neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Brazil neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Argentina neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 84 Middle East & Africa neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Africa neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Saudi Arabia neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 UAE neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Kuwait neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 93 Key company categorization
  • Fig. 94 Strategic framework